Swiss National Bank
BHVN

Swiss National Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Swiss National Bank’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-143,200
Closed -$21.6M – 2795
2022
Q3 		$21.6M Buy
143,200
+1,900
+1% +$282K 0.02% 617
2022
Q2 		$20.6M Buy
141,300
+1,900
+1% +$243K 0.01% 624
2022
Q1 		$16.5M Buy
139,400
+9,800
+8% +$1.22M 0.01% 766
2021
Q4 		$17.9M Buy
129,600
+200
+0.2% +$25.4K 0.01% 726
2021
Q3 		$18M Buy
129,400
+10,500
+9% +$1.31M 0.01% 714
2021
Q2 		$11.5M Buy
118,900
+2,400
+2% +$195K 0.01% 939
2021
Q1 		$7.96M Buy
116,500
+1,800
+2% +$146K 0.01% 1139
2020
Q4 		$9.83M Buy
114,700
+1,900
+2% +$161K 0.01% 942
2020
Q3 		$7.33M Buy
112,800
+2,200
+2% +$144K 0.01% 963
2020
Q2 		$8.09M Buy
110,600
+24,600
+29% +$1.31M 0.01% 878
2020
Q1 		$2.93M Buy
86,000
+1,200
+1% +$54.9K ﹤0.01% 1217
2019
Q4 		$4.62M Buy
84,800
+2,600
+3% +$129K ﹤0.01% 1205
2019
Q3 		$3.43M Buy
82,200
+700
+0.9% +$29.6K ﹤0.01% 1332
2019
Q2 		$3.57M Buy
81,500
+44,700
+121% +$2.52M ﹤0.01% 1326
2019
Q1 		$1.89M Buy
36,800
+1,300
+4% +$56.2K ﹤0.01% 1694
2018
Q4 		$1.31M Buy
35,500
+1,600
+5% +$57.7K ﹤0.01% 1828
2018
Q3 		$1.27M Buy
33,900
+2,600
+8% +$95.6K ﹤0.01% 2006
2018
Q2 		$1.24M Hold
31,300
– – ﹤0.01% 2037
2018
Q1 		$806K Buy
31,300
+16,000
+105% +$478K ﹤0.01% 2197
2017
Q4 		$413K Buy
+15,300
New +$421K ﹤0.01% 2448

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Swiss National Bank's BHVN Position: Q4 2022 in Review

Swiss National Bank sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 143,200 shares — an estimated $21.6M sold.

Swiss National Bank first reported a position in BHVN in Q4 2017 and held it in 20 quarters. The position peaked at $21.6M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Swiss National Bank reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Swiss National Bank sold 143,200 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $21.6M.
  • Swiss National Bank first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 20 quarters.
  • Swiss National Bank's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $21.6M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.